We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPME:NYSESound Point Meridian Capital, Inc. 7.875% Series B Preferred Shares due 2030 Analysis

Data as of 2026-08-28 - not real-time

$24.87

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At $24.86, Sound Point Meridian Capital, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 1.7%. Momentum indicators put RSI at 42.3 (neutral) with MACD reading bearish. Watch $24.73 as support and $25.36 as the nearer resistance level.
Revenue is contracting at 35.3% on a -180.2% profit margin. The 7.87% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 10.4%, a beta of -0.01 and a maximum drawdown of 5.3%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 4 out of 10.

Top Market Events

Updated May 27, 2026 0 NEW YORK-- BUSINESS WIRE --May 27, 2026-- Sound Point Meridian Capital, Inc.donanimhaber.com3monSound Point Meridian Capital Preferred SPME Holds Steady at $25.09 — A Fixed-Income Anchor in...Seeking Alpha15dSound Point Meridian signals $0.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 25.10
  • MACD momentum is negative
  • Thin trading liquidity raises execution risk

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 25.10
  • MACD momentum is negative
  • Thin trading liquidity raises execution risk

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Negative profit margin of -180.2%
  • Revenue contracting at -35.3%
  • Dividend yield of 7.87%

Key Metrics & Analysis

Financial Health

Revenue Growth-35.30%
Profit Margin-180.17%
Debt/Equity28.83
P/B Ratio2.6
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI42.3
Support$24.73
Resistance$25.36
MA 20$25.07
MA 50$25.14
MA 200$25.10
MACDBearish
VolumeIncreasing
Fear & Greed Index95.52

Valuation

GradeFair
TypeValue
Dividend Yield7.87%

Risk Assessment

Beta-0.01
Volatility10.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.